Australia, April 24 -- Ascendis Pharma Growth Disorders A.S, owns the trademark (2517822) for 'WELMYLI' till Oct. 25, 2034.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations for the treatment of growth disorders; pharmaceutical preparations for the treatment of endocrine disorders; pharmaceutical preparations for the treatment of bone disorders; pharmaceutical preparations for the treatment of skeletal disorders; pharmaceutical preparations for the treatment of genetic disorders affecting bone and skeletal growth; pharmaceutical preparations for the treatment of osteochondrodysplasia, achondroplasia and hypochondroplasia; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, skeletal disorders, osteochondrodysplasia, achondroplasia and hypochondroplasia.] and 10 [Medical devices for injection, dosage and control of pharmaceuticals, namely medical devices for injection, dosage and control of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, skeletal disorders, osteochondrodysplasia, achondroplasia and hypochondroplasia; medical devices for dosage and injection of pharmaceutical and medical preparations, namely pen-type syringes, medical auto-injectors, autoinjector syringes, injection needles, and autoinjector cartridges; syringes for medical purposes and for injections; syringes for injection for medical use, namely syringes in the form of pens for medical and surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of skeletal disorders, osteochondrodysplasia, achondroplasia and hypochondroplasia; medical apparatus, namely, infusion and injection devices for administering drugs; apparatus and instruments for diagnostic purposes, namely, dosage management dispensers for medicines containing software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic.]
Type of Mark: Word
Date of Acceptance: Feb. 12
Registration Advertised: April 23
For further details contact Abion IPR Aps .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2517822.
Disclaimer: Curated by HT Syndication.
